Collà Ruvolo Claudia, Würnschimmel Christoph, Wenzel Mike, Nocera Luigi, Celentano Giuseppe, Mangiapia Francesco, Tian Zhe, Shariat Shahrokh F, Saad Fred, Chun Felix H C, Briganti Alberto, Longo Nicola, Mirone Vincenzo, Karakiewicz Pierre I
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montreal, QC, Canada.
Urology Unit, Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
Int J Clin Oncol. 2021 Sep;26(9):1707-1713. doi: 10.1007/s10147-021-01941-9. Epub 2021 Jun 6.
The European Association of Urology guideline for upper tract urothelial carcinoma (UTUC) relies on two grading system: 1973 World Health Organization (WHO) and 2004/2016 WHO. No consensus has been made which classification should supersede the other and both are recommended in clinical practice. We hypothesized that one may be superior to the other.
Newly diagnosed non-metastatic UTUC patients treated with radical nephroureterectomy were abstracted from the Surveillance, Epidemiology, and End Results database (2010-2016). Kaplan-Meier plots and multivariable Cox regression models (CRMs) tested cancer-specific mortality (CSM), according to 1973 WHO (G vs. G vs. G) or to 2004/2016 WHO (low-grade vs. high-grade) grading systems. Haegerty's C-index quantified accuracy.
Of 4271 patients, according to 1973 WHO grading system, 134 (3.1%) were G, 436 (10.2%) were G and 3701 (86.7%) were G; while according to 2004/2016 WHO grading system, 508 (11.9%) were low grade vs 3763 (88.1%) high grade. In multivariable CRMs, high grade predicted higher CSM (Hazard ratio: 1.70, p < 0.001). Conversely, neither G (p = 0.8) nor G (p = 0.1) were independent predictors of worse survival. The multivariable models without consideration of either grading system were 74% accurate in predicting 5-year CSM. Accuracy increased to 76% after either addition of the 1973 WHO or 2004/2016 WHO grade.
From a statistical standpoint, either 1973 WHO or 2004/2016 WHO grading system improves the accuracy of CSM prediction to the same extent. In consequence, other considerations such as intra- and interobserver variability may represent additional metrics to consider in deciding which grading system is better.
欧洲泌尿外科学会关于上尿路尿路上皮癌(UTUC)的指南依赖于两种分级系统:1973年世界卫生组织(WHO)分级系统和2004/2016年WHO分级系统。对于哪种分类应取代另一种分类尚未达成共识,并且在临床实践中两种分级系统都被推荐使用。我们推测其中一种分级系统可能优于另一种。
从监测、流行病学和最终结果数据库(2010 - 2016年)中提取接受根治性肾输尿管切除术治疗的新诊断非转移性UTUC患者。根据1973年WHO分级系统(G1 vs. G2 vs. G3)或2004/2016年WHO分级系统(低级别vs.高级别),使用Kaplan - Meier曲线和多变量Cox回归模型(CRMs)来测试癌症特异性死亡率(CSM)。Haegerty的C指数用于量化预测准确性。
在4271例患者中,根据1973年WHO分级系统,134例(3.1%)为G1,436例(10.2%)为G2,3701例(86.7%)为G3;而根据2004/2016年WHO分级系统,508例(11.9%)为低级别,3763例(88.1%)为高级别。在多变量CRMs中,高级别预测更高的CSM(风险比:1.70,p < 0.001)。相反,G1(p = 0.8)和G2(p = 0.1)都不是生存较差的独立预测因素。不考虑任何一种分级系统的多变量模型在预测5年CSM方面的准确率为74%。在加入1973年WHO分级或2004/2016年WHO分级后,准确率提高到76%。
从统计学角度来看,1973年WHO分级系统或2004/2016年WHO分级系统在相同程度上提高了CSM预测的准确性。因此,在决定哪种分级系统更好时,诸如观察者内和观察者间变异性等其他因素可能是需要考虑的额外指标。